Historical record - last NADAC publication: 1/5/2018

Product Information

TEMODAR 20 MG CAPSULE is a brand product labeled by Merck Sharp & Dohme LLC, priced at $89.9177 per EA under NDC 00085151903. Its NADAC has been published 269 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the Temozolomide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TEMODAR 20 MG CAPSULE

Temozolomide
$89.9177per EA
High Outlier

Strength

20 mg/1

NDC

00085151903

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Last Updated

1/5/2018

Active Ingredients

TEMOZOLOMIDE

Approval Type

New Drug (NDA)

FDA Application

NDA021029

On Market Since

8/11/1999

Pharmacological Classes

Alkylating Activity
Alkylating Drug

Price Statistics

The NADAC for TEMODAR 20 MG CAPSULE has been published 269 times since Nov 28, 2013, and over the history we have for it it has risen 102.9%. The table below summarizes its recorded NADAC range and movement.

Current price$89.9177 per EA
All-time high$89.9177 (Jan 16, 2019)
All-time low$44.3147 (Nov 28, 2013)
Median price$68.1853
Average price$68.5793
Largest weekly change+9.9% (Jan 17, 2018)
Weeks tracked269
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+102.9%

Generic Alternatives

The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TEMODAR 20 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TEMODAR 20 MG CAPSULE, manufactured by Merck Sharp & Dohme LLC, is $89.9177 per EA (NDC 00085151903), effective Jan 16, 2019.

How has the price of TEMODAR 20 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for TEMODAR 20 MG CAPSULE has risen 102.9%. It has been tracked across 269 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for TEMODAR 20 MG CAPSULE?

Since Nov 28, 2013, the NADAC for TEMODAR 20 MG CAPSULE has ranged from a low of $44.3147 (Nov 28, 2013) to a high of $89.9177 (Jan 16, 2019), with a median of $68.1853 per EA.

Are there cheaper alternatives to TEMODAR 20 MG CAPSULE?

Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TEMOZOLOMIDE 20 MG CAPSULE, is $1.1527 per EA — about 99% below TEMODAR 20 MG CAPSULE.

Who manufactures TEMODAR 20 MG CAPSULE?

TEMODAR 20 MG CAPSULE (NDC 00085151903) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.

Related Drugs

Same classification

No related drugs found.